BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/13/2025 1:39:36 PM | Browse: 80 | Download: 531
 |
Received |
|
2025-02-18 08:28 |
 |
Peer-Review Started |
|
2025-02-18 08:28 |
 |
First Decision by Editorial Office Director |
|
2025-03-06 07:08 |
 |
Return for Revision |
|
2025-03-06 07:08 |
 |
Revised |
|
2025-03-21 09:17 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-04-21 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-04-21 07:50 |
 |
Articles in Press |
|
2025-04-21 07:50 |
 |
Edit the Manuscript by Language Editor |
|
2025-04-26 00:56 |
 |
Typeset the Manuscript |
|
2025-05-30 02:44 |
 |
Publish the Manuscript Online |
|
2025-06-13 13:39 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Prognostic value of preoperative fibrinogen, neutrophil-to-lymphocyte ratio, serum alpha-fetoprotein, and prealbumin for primary liver cancer undergoing trans-arterial chemoembolization
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qi-Qi Liu, Ya-Dong Li, Jia-Xin Chen, Lin-Lin Zhang, Rong-Chun Guan, Wei Zhao and Ling-Yu Meng |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Health Commission of Heilongjiang Province |
0230404080031 |
|
| Corresponding Author |
Ling-Yu Meng, Clinical Laboratory, The Third Affiliated Hospital of Qiqihar Medical University, No. 3 Taishun Street, Tiefeng District, Qiqihar 161000, Heilongjiang Province, China. 18345202361@163.com |
| Key Words |
Primary liver cancer; Trans-arterial arterial chemoembolization; Prognose; Fibrinogen and neutrophil-to-lymphocyte ratio score; Serum alpha-fetoprotein; Prealbumin |
| Core Tip |
This study investigates the prognostic value of combining fibrinogen and neutrophil-to-lymphocyte ratio (F-NLR) score, alpha-fetoprotein (AFP), and prealbumin (PA) in patients with primary liver cancer undergoing transarterial chemoembolization. Our findings indicate that integrating F-NLR, which reflects systemic inflammation and coagulation status, AFP as a marker of tumor burden, and PA as an indicator of nutritional status and liver function, significantly enhances prognostic accuracy. This combined approach provides a basis for personalized treatment strategies, enabling precise identification of high-risk patients and optimizing therapeutic plans to improve outcomes. |
| Publish Date |
2025-06-13 13:39 |
| Citation |
Liu QQ, Li YD, Chen JX, Zhang LL, Guan RC, Zhao W, Meng LY. Prognostic value of preoperative fibrinogen, neutrophil-to-lymphocyte ratio, serum alpha-fetoprotein, and prealbumin for primary liver cancer undergoing trans-arterial chemoembolization. World J Gastrointest Oncol 2025; 17(6): 103198 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i6/103198.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i6.103198 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.